2012年-世界发展银行全球_The_Economic_Costs_of_Noncommunicable_Diseases_in_the_Pacific_Islands___A_Rapid_Stocktake_of_the_Situation_in_Samoa_Tonga_and_Vanuatu_89页_1mb

Summary of The Economic Costs of Noncommunicable Diseases in the Pacific Islands

Core Content

This report provides a rapid stocktake of the economic and financial costs of Non-Communicable Diseases (NCDs) in Samoa, Tonga, and Vanuatu, with a focus on their impact on public health and government budgets. It highlights the growing burden of NCDs in the Pacific, the underlying risk factors, and the implications for both health and financial policy.

Main Findings

1. NCDs as a Major Health and Economic Challenge

• NCDs are the leading cause of death in twelve Pacific Island Countries, often accounting for 70% of all deaths.
• In Tonga, 48% of all deaths occur before the age of 64, primarily due to cardiovascular disease.
• Cardiovascular disease (CVD) is the most common cause of death in the Pacific, often occurring at twice the rate of traditional communicable diseases.
• Diabetes is a particularly significant NCD in the Pacific, with some of the highest global prevalence rates.
• Premature deaths from NCDs are common in Tonga, Samoa, and Vanuatu, with at least one quarter of NCD deaths occurring before the age of 60.

2. Risk Factors for NCDs in the Pacific

• Obesity and overweight are widespread, with 60% of adults in ten Pacific countries overweight and 75% in six countries.
• Obesity rates are particularly high among youth, with nearly one in four boys and one in five girls in Tonga being obese.
• Tobacco and alcohol use are significant risk factors, with over two-thirds of people in Kiribati smoking daily and over 70% in the Cook Islands being physically inactive.
• Combined risk factors such as smoking, poor nutrition, alcohol use, and physical inactivity ("SNAP") contribute to the high incidence of NCDs.

3. Financial and Economic Costs

• Governments in the Pacific account for 90% (Vanuatu), 87% (Samoa), and 81% (Tonga) of total health expenditure.
• NCDs impose high costs on health systems, with treatment costs increasing significantly as care moves from health centres to hospitals.
• Dialysis costs in Samoa for diabetes-related kidney failure were estimated at $38,686 per patient per year, which is more than twelve times the country's Gross National Income.
• Glucose testing strips cost $164 per patient per year, exceeding the total per capita government health expenditure.
• Health expenditure per capita in Samoa, Tonga, and Vanuatu is at least double that of other lower middle-income countries.

4. Implications for Policymakers

• Ministers of Health must address the multi-sectoral nature of NCD risk factors, which often lie beyond the health sector.
• Ministers of Finance and Planning face challenges in allocating resources due to limited fiscal space and subdued economic growth.
• The demographic dividend of a large working-age population is at risk due to the reduced productivity and increased health costs associated with NCDs.
• Primary and secondary prevention offer significant cost savings and health benefits:
  • Avoiding dialysis saves the government $38,700 per year per person in Samoa.
  • Lifestyle changes in Vanuatu that prevent Type 2 diabetes can save $347 per year per person.
  • Stabilising diabetes patients through secondary prevention can save $484 per year per person over an oral medication regime.

5. Strategic Opportunities

• Tobacco taxation can have a double benefit: reducing NCD risk factors and generating revenue for governments.
• Alcohol, junk food, and soft drinks with high sugar, fat, and salt content should be taxed more heavily.
• Investing in young female health and antenatal care can break the inter-generational transfer of metabolic risks and NCDs.
• A coherent approach to health system financing and operations is needed to address both communicable diseases and NCDs.

Key Information

• Exchange rates (as of 30 June 2012) are provided for reference:
  • 1 Samoan Tala (SAT) = US$0.41
  • 1 US$ = SAT 2.41
  • 1 Tongan Pa'anga (TOP) = US$0.55
  • 1 US$ = TOP 1.79
  • 1 Vanuatu Vatu (Vt) = US$0.0107
  • 1 US$ = Vt 93
• The report is a technical assistance document and not part of the World Bank's formal Economic and Sector Work studies.
• Data limitations are acknowledged, particularly in mortality and health reporting across the Pacific.
• Previous studies show that NCDs cost more than most communicable diseases in the Pacific, with health expenditure often coming from government budgets.

Conclusion

This report underscores the urgent need for coordinated action between health and finance ministries to address the rising burden of NCDs in the Pacific. It emphasizes the importance of prevention, the economic impact of NCDs, and the potential for cost-effective interventions that align with both public health and fiscal goals. The findings serve as a basis for policy discussion and future action.